SMAD-Mediated TGFβ Family Signaling Regulates Epithelial Cell Fate in the Developing Vagina Through Expression of ΔNp63.

Monica M. Laronda,Kenji Unno,Lindsey M. Butler,Vanida A. Serna,Alea A. Mills,Richard R. Behringer,Chuxia Deng,Satrajit Sinha,Takeshi Kurita

DOI: https://doi.org/10.1093/biolreprod/87.s1.147

2012-01-01

Biology of Reproduction

Abstract:Both the uterine and vaginal epithelia are derived from the Müllerian duct epithelium (MDE). Paracrine factors from the mesenchyme initiate organ-specific epithelial cell fate decisions: uterine mesenchyme induces MDE to remain columnar and form glands, while vaginal mesenchyme induces MDE to differentiate as stratified squamous epithelium. Previously, we demonstrated that induction of transformation related protein 63 (p63) by vaginal mesenchyme is essential for MDE to become vaginal epithelium. In this study, we specifically inactivated the ΔN isoform, the predominant isoform of p63 in vaginal epithelium, in MDE. Vaginal epithelium without the ΔN isoform remained columnar and did not differentiate into squamous cells, indicating that the TA isoform of p63 is dispensable and the ΔN isoform is required for vaginal epithelial differentiation. Microarray and semi-quantitative real time PCR analyses were performed to search for mesenchymal factors that regulate expression of ΔNp63. These analyses identified TGF-β ligands, namely Activin A (Inhba) and bone morphogenetic protein 4 (Bmp4), as factors that are highly expressed in the vaginal mesenchyme when compared to uterine mesenchyme. In addition, there were multiple Smad binding elements upstream of the ΔNp63 transcription start site, and SMAD4 bound directly to the sequence in vaginal but not uterine epithelium from neonatal mice. From these data we hypothesized that Activin A and BMP4 signaling mediated by SMADs controls the cell fate decision in MDE to be vaginal epithelium via expression of ΔNp63. Indeed, treatment of neonatal mouse uteri with BMP4 and Activin A, in combination, induced expression of ΔNp63 and subsequent squamous differentiation of uterine epithelium. Furthermore, the essential role of SMAD-mediated signaling in the cell fate decision of vaginal epithelium was confirmed by conditional inactivation of Smad4 in MDE. The vaginal epithelium of Smad4 conditional knockout mice was negative for ΔNp63 and remained columnar. Our array analysis and immunohistochemistry demonstrated that RUNX1, a known partner of Smad-mediated transcription, was also highly expressed in vaginal but not uterine epithelium of neonatal mice. The vaginal epithelium of Runx1 conditional knockout mice contained dramatically fewer P63-positive cells, and therefore fewer squamous cells, in the vaginal epithelium. Thus, we concluded that epithelial cell fate in the vagina is controlled by activation of ΔNp63 by a SMAD/RUNX complex, which is induced by mesenchymal Activin A and BMP4. Loss of p63 expression in vaginal epithelium leads to adenosis with uterine-like morphology. From the 1940s to the 1970s approximately 5 million pregnant women were given diethylstilbestrol (DES), a synthetic, non-steroidal estrogen, to prevent miscarriages. Women exposed to DES in utero have a high prevalence of vaginal adenosis and adenocarcinoma. It is still unclear how DES causes these anomalies. Mechanistic studies of normal vaginal development are essential for understanding the pathogenesis of vaginal adenosis and adenocarcinoma. This research is supported by the NIH/NCI R01 CA154358.